Clal Biotechnology Industries Limited operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Clal Biotechnology Industries Limited with three other
companies in this sector in Israel:
Arcturus Therapeutics Ltd
sales of 56.79 million Israel Shekels [US$16.43 million]
Redhill Biopharma Ltd
(30.14 million Israel Shekels [US$8.72 million]
Collplant Holdings Ltd
(18.03 million Israel Shekels [US$5.22 million]
Clal Biotechnology Industries Limited reported sales of 77.06 million Israel Shekels (US$22.29 million)
December of 2018.
increase of 41.4%
versus 2017, when the company's sales were 54.50 million Israel Shekels.
Sales of Other saw an increase
that was more than double the company's growth rate: sales were up
573.3% in 2018, from
29.21 million Israel Shekels to 196.66 million Israel Shekels.
Clal Biotechnology Industries Limited also saw significant increases in sales in
Medivned (up 404.9% to 58.45 million Israel Shekels)